Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a hemodialysis center

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 25, Issue 8, 2006, Pages 527-531

  Kondili, L A ^a   Genovese, D ^a   Argentini, C ^a   Chionne, P ^a   Toscani, P ^b   Fabro, R ^b   Cocconi, R ^b   Rapicetta, M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; VIRUS DNA; VIRUS RNA;

ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTACT EXAMINATION; CONTROLLED STUDY; EPIDEMIC; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; ITALY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEROCONVERSION; SEROEPIDEMIOLOGY; VIRUS ISOLATION; VIRUS TRANSMISSION;

DISEASE OUTBREAKS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; IMMUNIZATION; ITALY; PATIENT CARE TEAM; RENAL DIALYSIS; VIRAL HEPATITIS VACCINES;

EID: 33747353597     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-006-0162-7     Document Type: Article

References (13)

1. Forns X, Fernàndez-Llama P, Pons M, Costa J, Ampurdanes S, Lopez-Labrador FX, Olmedo E, Lopez-Pedret J, Darnell A, Revert L, Sanchez-Tapias JM, Rodes J (1997) Incidence and risk factors of hepatitis C virus infection in a hemodialysis unit. Nephrol Dial Transplant 12:736-740
2. Jadoul M, Cornu C, Van Ypersele de Strihou C (1993) Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int 44:1322-1326
3. Tokars JI, Miller ER, Alter MJ, Arduino MJ (1998) National surveillance of dialysis associated diseases in the United States, 1995. ASAIO J 44:98-107
4. Centers for Disease Control and Prevention (2001) Recommendations for preventing transmission of infections among chronic haemodialysis patients. MMWR 50:1-43
5. Genovese D, Dettori S, Argentini C, Villano U, Chionne P, Angelico M, Rapicetta M (2005) Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J Clin Microbiol 4:1902-1909
6. Günther S, Li BC, Miska S, Krüger DH, Meisel H, Will H (1995) A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69:5437-5444
7. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680
8. Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41:95-98
9. Kumar S, Tamura K, Jakobsen IB, Nei M (2001) MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245
10. Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 85:3173-3188
11. Kidd-Ljunggren K, Miyakawa Y, Kidd AH (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83:1267-1280
12. Simon N, Cououce A-M, Lemarrec N, Trepo C, Ducamp S (1994) A twelve year natural history of hepatitis C virus infection in hemodialysis patients. Kidney Int 46:504-511
13. Sampietro M, Graziani G, Badalamenti S, Salvatori S, Caldarelli R, Como G, Fiorelli G (1994) Detection of hepatitis C virus in dialysate and in blood ultrafiltrate of HCV-positive patients. Nephron 68:140